tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
US Market

Clinuvel Pharmaceuticals (CLVLF) Ratios

Compare
43 Followers

Clinuvel Pharmaceuticals Ratios

CLVLF's free cash flow for Q2 2026 was AU$0.56. For the 2026 fiscal year, CLVLF's free cash flow was decreased by AU$ and operating cash flow was AU$0.30. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
14.64 9.66 8.81 7.44 10.24
Quick Ratio
14.17 9.34 8.39 7.06 10.10
Cash Ratio
2.02 8.24 7.29 0.94 2.00
Solvency Ratio
1.63 1.21 1.31 1.05 1.12
Operating Cash Flow Ratio
2.27 1.51 1.47 1.45 2.90
Short-Term Operating Cash Flow Coverage
131.99 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 240.70MAU$ 232.03MAU$ 193.95MAU$ 159.72MAU$ 121.33M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.08 1.13 1.14 1.18 1.15
Debt Service Coverage Ratio
97.81 9.37 9.26 9.83 9.51
Interest Coverage Ratio
0.00 10.25 10.78 12.81 14.55
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.10 0.10 0.08 0.07
Net Debt to EBITDA
-0.86 -3.91 -3.25 -0.49 -0.75
Profitability Margins
Gross Profit Margin
63.71%83.29%91.23%64.59%70.93%
EBIT Margin
42.14%58.95%62.52%62.27%55.68%
EBITDA Margin
43.25%60.20%63.82%59.20%53.37%
Operating Profit Margin
39.39%48.13%54.44%52.23%50.34%
Pretax Profit Margin
45.90%54.26%57.47%58.19%52.22%
Net Profit Margin
33.79%38.07%40.41%39.08%31.77%
Continuous Operations Profit Margin
33.79%38.07%40.41%39.08%31.77%
Net Income Per EBT
73.62%70.17%70.32%67.15%60.83%
EBT Per EBIT
116.52%112.73%105.57%111.41%103.74%
Return on Assets (ROA)
12.07%13.31%15.42%15.73%14.42%
Return on Equity (ROE)
13.29%15.02%17.55%18.59%16.63%
Return on Capital Employed (ROCE)
15.06%18.70%23.31%24.20%25.24%
Return on Invested Capital (ROIC)
11.07%13.10%16.36%16.22%15.32%
Return on Tangible Assets
12.07%13.32%15.43%15.76%14.45%
Earnings Yield
6.81%6.96%4.57%3.46%2.85%
Efficiency Ratios
Receivables Turnover
5.81 3.46 3.36 3.53 4.06
Payables Turnover
3.27 6.23 3.30 9.93 73.71
Inventory Turnover
4.15 1.80 0.73 2.91 10.43
Fixed Asset Turnover
14.85 13.33 11.42 27.47 24.34
Asset Turnover
0.36 0.35 0.38 0.40 0.45
Working Capital Turnover Ratio
0.40 0.44 0.49 0.54 0.59
Cash Conversion Cycle
39.22 249.62 499.48 192.08 120.03
Days of Sales Outstanding
62.85 105.49 108.61 103.53 89.98
Days of Inventory Outstanding
87.87 202.75 501.57 125.29 35.00
Days of Payables Outstanding
111.51 58.62 110.70 36.74 4.95
Operating Cycle
150.73 308.24 610.18 228.82 124.98
Cash Flow Ratios
Operating Cash Flow Per Share
0.81 0.82 0.73 0.75 0.81
Free Cash Flow Per Share
0.80 0.81 0.62 0.73 0.80
CapEx Per Share
<0.01 <0.01 0.11 0.02 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 0.85 0.97 0.99
Dividend Paid and CapEx Coverage Ratio
13.97 14.66 4.61 12.29 23.88
Capital Expenditure Coverage Ratio
103.72 137.64 6.64 35.92 91.78
Operating Cash Flow Coverage Ratio
118.64 77.75 42.12 36.92 31.73
Operating Cash Flow to Sales Ratio
0.42 0.43 0.42 0.47 0.61
Free Cash Flow Yield
8.38%7.85%4.04%4.06%5.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.78 14.37 21.88 28.87 35.14
Price-to-Sales (P/S) Ratio
5.00 5.47 8.84 11.28 11.16
Price-to-Book (P/B) Ratio
1.93 2.16 3.84 5.37 5.84
Price-to-Free Cash Flow (P/FCF) Ratio
12.01 12.74 24.77 24.62 18.61
Price-to-Operating Cash Flow Ratio
11.89 12.65 21.04 23.93 18.40
Price-to-Earnings Growth (PEG) Ratio
-1.52 0.00 1.36 0.61 -2.20
Price-to-Fair Value
1.93 2.16 3.84 5.37 5.84
Enterprise Value Multiple
10.70 5.18 10.60 18.56 20.17
Enterprise Value
442.45M 296.21M 596.62M 860.59M 707.59M
EV to EBITDA
10.62 5.18 10.60 18.56 20.17
EV to Sales
4.59 3.12 6.77 10.99 10.77
EV to Free Cash Flow
11.04 7.26 18.95 23.98 17.94
EV to Operating Cash Flow
10.93 7.21 16.10 23.31 17.75
Tangible Book Value Per Share
4.96 4.81 3.97 3.32 2.53
Shareholders’ Equity Per Share
4.96 4.81 3.98 3.33 2.54
Tax and Other Ratios
Effective Tax Rate
0.26 0.30 0.30 0.33 0.39
Revenue Per Share
1.92 1.90 1.73 1.59 1.33
Net Income Per Share
0.65 0.72 0.70 0.62 0.42
Tax Burden
0.74 0.70 0.70 0.67 0.61
Interest Burden
1.09 0.92 0.92 0.93 0.94
Research & Development to Revenue
0.08 0.08 0.03 0.02 0.02
SG&A to Revenue
0.27 0.28 0.02 0.02 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.07 0.11 0.09
Income Quality
1.24 0.00 1.04 1.21 1.91
Currency in AUD